Haiti vs Peru: HIV/AIDS deaths averted by antiretroviral therapy
Haiti
8,513 deaths
in 2024
Peru
6,549 deaths
in 2024
Haiti rank
27th
Peru rank
30th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Haiti
- Peru
How they compare
Haiti currently reports 8,513 deaths against 6,549 deaths in Peru, a difference of 1,964 deaths.
That makes Haiti's figure about 1.3 times Peru's.
The two have swapped places 5 times across 35 shared years of data; in 1990 it was Peru ahead.
Haiti ranks 27th and Peru ranks 30th of 157 countries.
Haiti has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Haiti | Peru | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,003 deaths | 908.88 deaths | 94.1 deaths | Haiti |
| 2010s | 4,307 deaths | 4,028 deaths | 278.75 deaths | Haiti |
| 2020s | 8,123 deaths | 6,039 deaths | 2,085 deaths | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Haiti or Peru?
- Haiti, at 8,513 deaths against 6,549 deaths in Peru as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Haiti and Peru?
- 1,964 deaths, with Haiti ahead.
- How many years of comparable data are there for Haiti and Peru?
- 35 years are reported by both, from 1990 to 2024.
- How do Haiti and Peru rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Haiti ranks 27th and Peru ranks 30th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.